Driving their expertise in genomics-based health and disease testing, Genetic Technologies (ASX: GTG) has partnered CancerIQ, a widely used platform…
In 2022, over 24k Aussie males were diagnosed with prostate cancer. One of the most commonly diagnosed cancers, it was…
In 2018, breast cancer was the most commonly diagnosed cancer in Australia. A position it held until 2022. What’s more?…
Expectant parents in Europe will soon have access to leading prenatal testing kits that are widely utilised in Australia to…
The one-size-fits-all approach to medicine is on its way out with the rise of personalised medicine. The development of technologies…
With 1 in 8 Australians suffering from depression, the market for antidepressants is a growing one but one which medical…